As biologics manufacturing operations become increasingly complex, biopharma companies are under growing pressure to improve efficiency, strengthen contamination control and meet evolving regulatory expectations without compromising product q... Read more
As pharmaceutical companies continue to face high attrition rates, rising development costs and increasingly complex clinical datasets, the industry is searching for more predictive approaches to drug discovery and development. In this exclusive Q&am... Read more
Fluid overload remains one of the most complex and costly challenges in cardiorenal care, particularly for patients who no longer respond to conventional diuretic therapies. As healthcare systems increasingly prioritize precision medicine, proactive ... Read more
Central nervous system (CNS) cancers remain among the most difficult diseases to treat in oncology, with limited therapeutic options, complex delivery challenges and poor patient outcomes continuing to hinder progress. As interest in targeted... Read more
Highly potent drugs now account for over 30% of the global pipeline, with more than 1,000 molecules in development — Axplora’s investments in HPAPI capacity help customers bring these complex therapies to market faster $60 ... Read more
Expands Agilent’s pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be accretive to Agilent’s top-line gro... Read more
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi – Drug Substance Facility 5 (MFG5), Drug Product Facility 2 ... Read more
"In the first quarter, Samsung Biologics delivered stable growth, supported by consistent execution across our manufacturing network and continued demand from clients," said John Rim, President and CEO of Samsung Biologics. "With full operations in p... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
